Rescriptor
Active substance: Delavirdine
Manufacturer: Pfizer (USA) / Roche (Switzerland)
Extract from the prescribing information:
"Patients should be informed that RESCRIPTOR is not a cure for HIV-1 infection and that they may continue to acquire illnesses associated with HIV-1 infection, including opportunistic infections. Treatment with RESCRIPTOR has not been shown to reduce the incidence or frequency of such illnesses, and patients should be advised to remain under the care of a physician when using RESCRIPTOR. Patients should be advised that the use of RESCRIPTOR has not been shown to reduce the risk of transmission of HIV-1."
Known side effects: more immune deficiency
“Hemic and Lymphatic System: Adenopathy, bruising, eosinophilia, granulocytosis, leukopenia, pancytopenia, purpura, spleen disorder, thrombocytopenia, and prolonged prothrombin time.”
Leukopenia = Decrease of all white blood cells
Pancytopenia = ?
Thrombocytopenia = ?
The above has been extracted from the Rescriptor prescribing information on the Pfizer webpages.